Keros Therapeutics Inc (KROS)

Total Costs & Expenses

$30.94M

Quarterly · Period ending: · USD

KROS logo

KROS Total Costs & Expenses

Latest reported$30.94M
KROS Quarterly Total Costs & Expenses ($5.36M → $30.94M)
High-resolution chart · PNG

KROS total costs & expenses history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Keros Therapeutics Inc Total Costs & Expenses — Quarterly (USD)
Period endingTotal Costs & Expenses (USD)
30,937,000
26,244,000
29,655,000
29,646,000
57,985,000
59,206,000
56,296,000
59,045,000
50,476,000
48,566,000
46,598,000
43,288,000
41,337,000
38,869,000
31,960,000
27,976,000
30,728,000
24,126,000
24,867,000
20,197,000
15,641,000
15,769,000
13,291,000
11,948,000
10,914,000
10,504,000
5,228,000
4,826,000
5,151,000
5,358,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.